Damage to the skin and surrounding tissue from radiation may also prevent the placement of a PICC line. To help prevent the line from becoming clogged, the line should be regularly flushed with normal saline, and "locked" by filling it with heparin or normal saline when not in use.Ī PICC line may not be inserted in a part of the body which is burned or has a local infection. They may also be used to obtain a blood sample if the lumen is of sufficient size (at least 4 French gauge). They are commonly used in people receiving total parenteral nutrition (TPN), chemotherapy, or long term medications such as antibiotics. They are utilized in both the hospital and community settings. A PICC line can remain inserted for an extended period of time compared to other forms of central IV access, ranging from seven days up to several months as long as the line remains viable. Generally, PICC lines are considered when a person is expected to need more than two weeks of intravenous therapy. Subclavian and jugular line placements may result in pneumothorax (air in the pleural space of lung), while PICC lines have no such issue because of the method of placement.Ī PICC (upper arm) and IV line (elbow area) inserted prior to chemotherapy. It is a catheter that enters the body through the skin (percutaneously) at a peripheral site, extends to the superior vena cava (a central venous trunk), and stays in place (dwells within the veins) for days, weeks or even months.įirst described in 1975, it is an alternative to central venous catheters in major veins such as the subclavian vein, the internal jugular vein or the femoral vein. A peripherally inserted central catheter ( PICC or PIC line), less commonly called a percutaneous indwelling central catheter, is a form of intravenous access that can be used for a prolonged period of time (e.g., for long chemotherapy regimens, extended antibiotic therapy, or total parenteral nutrition) or for administration of substances that should not be done peripherally (e.g., antihypotensive agents a.k.a.
0 kommentar(er)
